Eric Weisblum bought $4,847 of SILO
Chief Executive Officer at Silo Pharma, Inc.. 12,000 shares at an average of $0.40, traded Nov 18, 2025, filed Nov 20, 2025.
Score components
- +25RoleCEO
- 0Trade size$5k at market
- +3Relative to holdingsHoldings up 6%
- +18Price context2% above the 52-week low; 79% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.4%, 3m -19.0%, 6m +3.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-113104, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | POpen-market purchase Common Stock | +7,500 | $0.40 | $3,025 | 205,432 | Nov 20, 2025 |
| Nov 19, 2025 | POpen-market purchase Common Stock | +4,500 | $0.41 | $1,823 | 209,932 | Nov 20, 2025 |
Related signals
Other insiders at Silo Pharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $2,075 5,000 shares | +2% | |
| 43Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $735 2,000 shares | +1% | |
| 46Moderate | SILObuy Silo Pharma, Inc. | Eric Weisblum Chief Executive Officer | $4,329 10,000 shares | +5% | |
| 30Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $2,097 2,500 shares | +1% | |
| 25Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $4,625 5,000 shares | +3% | |
| 28Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,137 700 shares | +0% | |
| 28Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,668 1,100 shares | +1% | |
| 38Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,376 1,000 shares | +1% | |
| 33Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $3,100 2,000 shares | +1% | |
| 28Weak | SILObuy Silo Pharma, Inc. | Eric Weisblum CEO and President | $1,117 650 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.